Application by Regeneron Pharmaceuticals Inc. to take discovery from Biogen Inc. “for use in foreign patent-infringement litigation and related proceedings brought by Regeneron against Samsung Bioepis Co., Ltd., and Samsung Biologics Co., Ltd., currently pending in South Korea”, filed at the U.S. District Court for the District of Delaware.
- Home
- Documents
- Type
- Court Filings
- Application
- Regeneron Pharmaceuticals Inc. v. Biogen Inc.: Discovery Application (South Korea)
Application Civil Courts Discovery Documents South Korea United States District Court for the District of Delaware USAApril 27, 2023
Regeneron Pharmaceuticals Inc. v. Biogen Inc.: Discovery Application (South Korea)
35
April 27, 2023
Regeneron Pharmaceuticals Inc.
Topics
South Korea USAKeywords
Biogen Regeneron Pharmaceuticals Samsung